Nitric oxide and the respiratory system

Current Science

Volumn 85, Issue 5, 2003, Pages 607-614

  Himashree, G ^a   Dass, Deepak ^a   Banerjee, P K ^a   Selvamurthy, W ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

XENOX;

EID: 4444289375     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Ignarro, I. J., Buga, G. M., Wood, K. S., Byrns, R. E. and Chaudhuri, G., Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA, 1987, 84, 9265-9269.
2. Michelakis, E., Tymchak, W., Lien, D., Webster, L., Hashimoto, K. and Archer, S., Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation, 2002, 105, 2398-2403.
3. Palmer, R. M., Ferrige, A. G. and Moncada, S., Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature, 1987, 327, 524-526.
4. Frostell, C., Fratacci, M. D., Wain, J. C., Jones, R. and Zapol, W. M., Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation, 1991, 83, 2038-2047.
5. Anne Greenough, Nitric oxide - Clinical Aspects. Care Crit. Ill, 1995, 11, 143-146.
6. Ward, M. P., Milledge, J. W. and West, J. B. (eds), High Altitude Medicine and Physiology, Chapman & Hall, London, 1989.
7. Jerome and Severinghaus, J. W., High altitude pulmonary edema. N. Engl. J. Med., 1996, 334, 662.
8. Frostell, C. G., Blomqvist, H., Hedenstierna, G., Lundberg, J. and Zapol, W. M., Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology, 1993, 78, 427-435.
9. West, J. B., Tsukimoto, K., Mathieu-Costello, O. and Prediletto, R., Stress failure in pulmonary capillaries. J. Appl. Physiol., 1991, 70, 1731-1742.
10. Whayne, T. F. Jr. and Severinghaus, J. W., Experimental hypoxic pulmonary edema in the rat. J. Appl. Physiol., 1968, 25, 729-772.
11. Severinghaus, J. W., Transarterial leakage: a possible mechanism of high altitude pulmonary oedema. In High Altitude Physiology: Cardiac and Respiratory Aspects (eds Porter, R. and Knight, J.), Churchill Livingstone, London, 1971, pp. 61-77.
12. Scherrer, U. et al., Inhaled nitric oxide for high-altitude pulmonary edema. N. Engl. J. Med., 1996, 334, 624-629.
13. Wang, W., Zhang, X. and Ma, Y., Low-concentration nitrous oxide inhalation in the treatment of high-altitude pulmonary edema. Zhonghua Jie He He Hu Xi Za Zhi, 1998, 21, 212-214.
14. Day, R. W., Lynch, J. M., White, K. S. and Ward, R. M., Acute response to inhaled nitric oxide in newborns in respiratory failure and pulmonary hypertension. Pediatrics, 1996, 98, 698-705.
15. Barefield, E., Karle, V. A., Phillips, J. B. III and Carlo, W. A., Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J. Pediatr., 1996, 129, 279-286.
16. Roberts, J. D. Jr. et al., Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N. Engl. J. Med., 1997, 336, 605-610.
17. Kinsella, J. P. et al., Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J. Pediatr., 1997, 131, 55-62.
18. Wessel, D. L. et al., Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics, 1997, 100, E7.
19. Davidson, D. et al. and the INO/PPHN Study Group. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics, 1998, 101, 325-334.
20. The Franco-Belgium Collaborative NO Trial Group. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomized controlled trial. Lancet, 1999, 354, 1066-1071.
21. Omura, A., Roy, R. and Jennings, T., Inhaled nitric oxide improves survival in the rat model of high-altitude pulmonary edema. Wilderness Environ. Med., 2000, 11, 251-256.
22. Anand, I. S. et al., Effects of inhaled nitric oxide and oxygen in high-altitude pulmonary edema. Circulation, 1998, 98, 2441-2445.
23. Dellinger, R. P. et al., Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase trial. Crit. Care Med., 1998, 26, 15-23.
24. Lunn, R., Subspecialty clinics: Anesthesiology; Inhaled nitric oxide therapy. Mayo Clin. Proc., 1995, 70, 247-255.
25. Rossaint, R., Falke, K. J., Lopez, F., Slama, K., Pison, U. and Zapol, W. M., Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med., 1993, 328, 399-405.
26. Neonatal Inhaled Nitric Oxide Study Group, Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N. Engl. J. Med., 1997, 336, 597-604.
27. Sartori, C. et al., Salmeterol for the prevention of high altitude pulmonary edema. N. Engl. J. Med., 2002, 346, 1631-1636.
28. Bärtsch, P., Maggiorini, M., Ritter, M., Noti, C., Vock, P. and Oelz, O., Prevention of high-altitude pulmonary edema by nifedipine. N. Engl. J. Med., 1991, 325, 1284-1289.
29. Maggiorini, M., Mountaineering and altitude sickness. Ther. Umsch., 2001, 58, 387-393.
30. Klocke, D. L., Decker, W. W. and Stepanek, J., Altitude-related illnesses. Mayo Clin. Proc., 1998, 73, 988-992.
31. Bärtsch, P., High altitude pulmonary edema. Annu. Rev. Med., 1996, 47, 267-284.
32. Hultgren, H. N., High-altitude pulmonary edema: current concepts. Adv. Exp. Med. Biol., 1995, 381, 15-25.
33. Ladner, E., Schobersberger, W., Sparr, H. and Pall, H., High altitude pulmonary edema at a medium height. A case report. Anaesthesia, 1994, 43, 183-186.
34. Hackett, P. H., Roach, R. C., Hartig, G. S., Greene, E. R. and Levine, B. D., The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: a comparison. Md. Med. J., 1993, 42, 641-645.
35. Oelz, O., Maggiorini, M., Ritter, M., Noti, C., Waber, U., Vock, P. and Bärtsch, P., Pathophysiology, prevention and therapy of altitude pulmonary edema. Schweiz. Med. Wochenschr., 1992, 122, 1151-1158.
36. Droma, Y. et al., Positive association of the endothelial nitric oxide synthase gene polymorphisms with high altitude pulmonary edema. Circulation, 2002, 43, 978-987.
37. Heidi, J. and Dalton, Inhaled nitric oxide: Medical miracle or passing fad? Respir. Care, 1998, 43, 978-987.
38. Anggard, E., Nitric oxide: Mediator, murderer and medicine. Lancet, 1994, 343, 1199-1206.
39. Saugstad, O. D., Does nitric oxide prevent oxidative mediated lung injury? Acta Paediatr., 2000, 89, 905-907.
40. Finer, N. N. and Barrington, K. J., Nitric oxide for respiratory failure in infants born at or near term (Cochrane Review). In The Cochrane Library, Issue 1, Update Software, Oxford, 1999.
41. Barrington, K. J. and Finer, N. N., Inhaled nitric oxide in preterm newborn infants with respiratory failure (Cochrane Review). In The Cochrane Library, Issue 1, Update Software, Oxford, 1999.
42. Scott, E. M., The relation of diaphorase of human erythrocytes to inheritance of methemoglobinemia. J. Clin. Invest., 1960, 39.
43. Hogman, M., Frostell, C., Arnberg, H. and Hedenstierna, G., Bleeding time prolongation and NO inhalation. Lancet, 1993, 341, 1664-1665.
44. Samama, C. M. et al., Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology, 1995, 83, 56-65.
45. Cheung, P. Y., Salas, E., Etches, P. C., Phillipos, E., Schulz, R. and Radomski, M., Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates. Lancet, 1998, 351, 1181-1182.
46. Bell, P. R. F., Bleeding time prolongation and NO inhalation. Lancet, 1993, 341, 1664.
47. Clark, R. H. et al. (Clinical Inhaled Nitric Oxide Research Group), Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N. Engl. J. Med., 2000, 342, 469-674.
48. Ruhnau, B. K., Iversen, S. and Qvist, J., Nitric oxide inhalation therapy in patients with acute respiratory distress syndrome. A retrospective analysis. Ugeskr. Laeg., 2000, 162, 331-334.
49. Nakagawa, T. A., Johnston, S. J., Falkos, S. A., Gomez, R. J. and Morris, A., Life-threatening status asthmaticus treated with inhaled nitric oxide. J. Pediatr., 2000, 137, 119-122.
50. Jones, P. R., Hooper, R. H., Stopp, N. and Moore, N. A., Nitric oxide delivery to the lung: a model. Eur. J. Anaesthesiol., 2000, 17, 160-167.
51. Thibeault, D. W., Rezaiekhaligh, M. H., Ekekezie, I. and Truog, W. E., Compressed air as a source of inhaled oxidants in intensive care units. Am. J. Perinatol., 1999, 16, 497-501.
52. Griese, M., Koch, M., Latzin, P. and Beck, J., Asthma severity, recommended changes of inhaled therapy and exhaled nitric oxide in children: a prospective, blinded trial. Eur. J. Med. Res., 2000, 5, 334-340.
53. Busch, T. et al., Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema. Am. J. Respir. Crit. Care Med., 2001, 163, 368-373.
54. Duplain, H., Sartori, C., Lepori, M., Egli, M., Allemann, Y., Nicod, P. and Scherrer, U., Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am. J. Respir. Crit. Care Med., 2000, 162, 221-224.
55. David, G. and Tinkelman, D. G., Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma, J. Asthma, The Official Journal of the Association for the Care of Asthma, Edited by National Jewish Medical and Research Center, Denver, Colorado, 1999, 36, 618-622.
56. Artlich, A., Hagenah, J. U., Jonas, S., Ahrens, P. and Goriner, L., Klinik für Pädiatrie, Lübeck, Germany, Exhaled nitric oxide in childhood asthma. Eur. J. Pediatr., 1996, 155, 698-701.
57. Nelson, B. V., Sears, S., Woods, J., Ling, C. Y., Hunt, J., Clapper, L. M. and Gaston, B., Expired nitric oxide as a marker for childhood asthma. J. Pediatr., 1997, 130, 423-427.
58. Marlene, G. and Gerlach, H., Exhaled nitric oxide. Respir. Care, 1999, 44, 349-357.
59. Cynthia, M. B. et al., Pulmonary nitric oxide in mountain dwellers. Nature, 2001, 414, 411-412.
60. Avital, A., Uwyyed, K., Berkman, N., Godfrey, S., Bar-Yishay, E. and Springer, C., Exhaled nitric oxide and asthma in young children. Pediatr. Pulmonol., 2001, 32, 308-313.
61. Chambers, D. C. and Ayres, J. G., Effects of nitrogen dioxide exposure and ascorbic acid supplementation on exhaled nitric oxide in healthy human subjects. Thorax, 2001, 56, 774-778.
62. Jones, S. L., Kittelson, J., Cowan, J. O., Flannery, E. M., Hancox, R. J., McLachlan, C. R. and Taylor, D. R., The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am. J. Respir. Crit. Care Med., 2001, 164, 738-743.
63. Yamamoto, Y. et al., Role of airway nitric oxide on the regulation of pulmonary circulation by carbon dioxide. J. Appl. Physiol., 2001, 91, 1121-1130.
64. Montuschi, P., Kharitonov, S. A. and Barnes, P. J., Exhaled carbon monoxide and nitric oxide in COPD. Chest, 2001, 120, 496-501.
65. Mychaskiw, G., Sachdev, V. and Heath, B. J., Sildenafil (Viagra) facilitates weaning of inhaled nitric oxide following placement of a biventricular-assist device. J. Clin. Anesth., 2001, 13, 218-220.